roll call logo placeholder image

Research Ban Should Be Overturned

Did you hear the one about the doctor talking with a just-diagnosed Alzheimer’s patient who says, “I have good news and bad news for you? The good news is we stand on the threshold of dramatic treatments and possibly a cure for your disease. The bad news is, the government is restricting our research.” As you may have guessed, this is no joke. It’s a story being played out every day in doctors’ offices around the country to patients newly diagnosed with such catastrophic conditions as Alzheimer’s, Parkinson’s, ALS, juvenile diabetes, spinal cord injuries and countless other illnesses.

Slideshow |

Back Play/Pause Forward Slideshow Image
Rep. Michele Bachmann, who recently suspended her campaign for the presidency, speaks at the 2012 Conservative Political Action Conference in Washington, D.C., on Feb. 9.
See More Multimedia
30 Hill Aides to Know

30 Hill Aides to Know

The clear expectation is Congress will get very little done this election year. But what does get accomplished, at least in the high-profile areas, will largely be the handiwork of an elite group of staffers — who combine policy expertise, political acumen and the trust of their lawmaker bosses to drive much of the legislative agenda.

RollCallPoliticsiPhoneApp_API

SIGN IN




OR

SUBSCRIBE

Receive daily coverage of the people, politics and personality of Capitol Hill.